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Purpose: Early age at menarche (AAM) has been associated with increased mortality and 
morbidity, including premature death from all causes, breast cancer and cardiovascular dis-
eases. The aim of this study was to examine the association between AAM and all-cause 
mortality.
Subjects and methods: A total of 12,409 women aged 25–94 years who took part in the fourth 
Tromsø Study in Norway during 1994–1995 were included in this prospective population-based 
study with a mean 18.7 years of follow-up. Multivariate Cox proportional hazard analysis was used 
to investigate the association between AAM and all-cause mortality with adjustment for known 
confounders (age, body mass index, physical activity, level of education and smoking history).
Results: During the 18.7 years of follow-up, a total of 2,203 women died. There was no 
association between AAM and all-cause mortality before or after adjusting for possible con-
founding factors.
Conclusion: This prospective study of 12,409 women did not find any association between 
AAM and all-cause mortality
Keywords: menarche, mortality, population-based, prospective, puberty
Introduction
Menarche is the first menstrual bleeding and represents the beginning of reproductive 
life. Average age at menarche (AAM) worldwide is 12 years, but it differs between 
girls according to ethnicity, living standard and lifestyle.1 Menarche normally occurs 
between the ages of 10 and 15 years, but the variability in normal age of menarche 
has been discussed.2 A major secular trend in AAM has been observed since the 19th 
century when the mean menarcheal age was approximately 17 years, and the decrease 
in AAM has been as rapid as 12 months per decade.3,4
Previous studies have shown an association between early AAM and earlier all-cause 
mortality,5 cardiovascular mortality,6–9 higher risk of breast cancer,10 cardiovascular 
disease (CVD),1,8 diabetes,11–16 obesity15,17 and metabolic syndrome.15,18–21 Early AAM 
has also been associated with psychological disorders, depression, smoking and alcohol 
use in adolescence and early sexual behavior.22–24
A systematic review of the literature found that 1-year increase in AAM was asso-
ciated with a 3% lower all-cause mortality (hazard ratio [HR] 0.97, 95% confidence 
interval [CI] 0.96–0.98).5
The aim of this study was to investigate the association between AAM and all-
cause mortality among women living in Tromsø, Norway. The hypothesis was that 
early menarche was associated with increased mortality.
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Tromsø is the largest city in the north of Norway, with 
72,681 inhabitants by January 1, 2015.25,26 The Tromsø Study, 
which is a population-based prospective study, first started 
in 1974 and is one of the largest epidemiological studies 
in Norway.26
The current analyses are based on the largest of the 
surveys (Tromsø 4) conducted during 1994–1995 and 
27,158 men and women participated. A total of 19,078 women 
aged 25–94 years were invited to Tromsø 4, of which 
14,293 women (75%) participated.26
Women who did not consent to contribute to informa-
tion for study (n=120), women who did not report AAM 
(n=1,763) and one woman who reported AAM of 33 years 
were excluded. Thus, 12,409 women were eligible for inclu-
sion in our study.
Included variables
The main independent variable was AAM in Tromsø 4. 
In a self-administered questionnaire, the women were asked 
“How old were you when you started menstruating (age)?” 
The continuous variable was recorded in the following 
groups: ,12 years and 12, 13, 14, 15 and .15 years. Only 
1.3% were 10 years or younger at menarche; this group 
was considered too small for comparison, and the youngest 
menarcheal group was therefore coded to ,12 years. 
We have previously found high reproducibility of informa-
tion concerning AAM with a 7-year time span in the current 
population.27
We also collected information about several other vari-
ables that may be associated with both AAM and mortality. 
Some of these variables were measured (eg, weight [kg], 
height [m], blood pressure [mmHg] and serum blood lipids 
[mmol/L]), and some were based on self-report (eg, smoking, 
physical activity [PA] at leisure, treatment for hyperten-
sion, prior CVDs or diabetes). Age at baseline was included 
as a continuous variable when the relationships between 
AAM and other risk factors were analyzed (Table 1). 
Hypertension was defined as mean systolic blood pressure 
of .150 mmHg or diastolic blood pressure of .95 mmHg 
or that the woman was a current user of blood-pressure-
lowering drugs. Body mass index (BMI, kg/m2) was grouped 
into four BMI groups: underweight (BMI ,18.5 kg/m2), 
normal weight (BMI 18.5–24.9 kg/m2), overweight (BMI 
25–29.9 kg/m2) and obesity (BMI $30.0 kg/m2). Cigarette 
smoking was classified as never, previously or current ciga-
rette smoking. PA (hours/week) was grouped into sedate 
(light PA ,1 hour/week), moderate (hard PA ,1 hour/week 
or light PA $1 hour/week) or active (hard PA $1 hour/
week). For some variables, there were some missing values, 
but these accounted for a small percentage of the total dataset 
and were not expected to influence the end result.
The following variables were, based on previous studies, 
considered to be possible confounders (and not mediators) 
of the relationship between AAM and total mortality: age, 
smoking, PA at leisure, BMI and level of education.
Follow-up and statistical analyses
Follow-up started with the date the participant attended the 
examination in Tromsø 4 in 1994–1995 and lasted until 
June 30, 2015, date of emigration or date of death, whichever 
came first. The unique 11-digit personal identification number 
assigned to all Norwegian residents was used for linkage 
between the study population and the Norwegian Cause of 
Death Registry and information regarding emigration held by 
Statistics Norway. The Cause of Death Registry covers data 
on all persons with residence in the country, independent of 
where they died. Mean duration of follow-up was 18.7 years. 
During this time, 2,203 women died and 140 emigrated.
The statistical analyses included cross-tabulations, linear 
regression (for continuous variables), binary logistic regres-
sion (for categorical variables) and Cox proportional hazard 
regression.
In the descriptive analyses of associations between AAM 
and possible confounders (Table 1), age at baseline was 
included as a covariate in the model to provide age-adjusted 
p-values for linear trend. When assessing the relationship 
between AAM and total mortality (Table 2), we applied 
Cox proportional hazard regression with attained age as the 
time variable.
In the Cox proportional hazard regression analyses, 
the reference categories were 13 years for AAM, less than 
university level of education, normal BMI, sedate activity 
level and never smokers.
Separate survival analyses were performed for women 
with attained age of 69 years or below and older women to 
examine whether there were differences in the relationship 
between AAM with increasing age. We ran similar stratified 
analyses for current, former and never smokers.
HR was interpreted as risk. 95% CIs were given. A two-
sided p-value of ,0.05 was considered statistically signifi-
cant. We used IBM Statistical Package for the Social Sciences 
(SPSS; IBM Corporation, Armonk, NY, USA) statistics 22 
and SAS 9.4 software (SAS Institute Inc., Cary, NC, USA) 
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age at menarche and total mortality: the Tromsø study
ethics and permission
Approval was given from the Data and Publication com-
mittee of the Tromsø Study and access to a data file with 
the described variables was received. The Tromsø Study 
is approved by the Regional Committee for Medical 
Research Ethics (REK) and the investigation is covered 
by this approval. All included subjects provided informed 
written consent.
Table 1 relationships between aaM and demographic and lifestyle variables
Variables AAM (years)






subjects (n) 9.0 (1,120) 19.6 (2,428) 27.6 (3,429) 24.9 (3,092) 13.3 (1,646) 5.6 (694)
age (years) 41.84 (12.12) 43.49 (13.66) 45.22 (14.58) 48.36 (15.56) 50.68 (16.02) 52.81 (16.83) ,0.001
% with hypertension 14.7 (165) 15.9 (385) 18.5 (631) 21.9 (677) 25.5 (419) 30.8 (213) ,0.001 0.006
BMI (kg/m2) 25.81 (4.64) 25.13 (4.33) 24.67 (4.14) 24.47 (4.07) 24.40 (3.97) 24.24 (4.10) ,0.001 ,0.001
BMI
Underweight 0.8 (9) 1.4 (33) 1.8 (62) 2.4 (75) 2.1 (34) 4.2 (29) ,0.001 ,0.001
normal weight 49.2 (549) 55.2 (1,339) 58.8 (2,009) 59.8 (1,848) 59.6 (981) 58.9 (408)
Overweight 33.9 (378) 30.6 (742) 28.5 (975) 27.7 (855) 29.2 (480) 27.4 (190)
Obesity 16.1 (180) 12.8 (309) 10.9 (371) 10.1 (311) 9.1 (150) 9.5 (66)
Total cholesterol (mmol/l) 5.81 (1.32) 5.94 (1.34) 5.93 (1.36) 6.12 (1.40) 6.23 (1.40) 6.29 (1.48) ,0.001 0.052
Triglycerides (mmol/l) 1.33 (0.83) 1.33 (0.85) 1.29 (0.83) 1.35 (0.85) 1.35 (0.87) 1.44 (1.01) 0.004 0.001
HDl (mmol/l) 1.60 (0.39) 1.62 (0.40) 1.64 (0.40) 1.66 (0.41) 1.67 (0.41) 1.65 (0.42) ,0.001 ,0.001
alcohol (times/month) 2.09 (2.76) 2.12 (2.99) 2.12 (3.05) 2.12 (3.23) 1.96 (2.92) 1.83 (3.32) 0.042 0.62
smoking
never 39.7 (432) 39.3 (924) 41.1 (1,376) 40.4 (1,226) 42.4 (687) 40.9 (274) 0.008 0.67
Previously 21.9 (238) 22.2 (521) 22.6 (758) 23.3 (708) 24.3 (394) 24.5 (164)
currently 38.5 (419) 38.5 (904) 36.3 (1,215) 36.3 (1,101) 33.3 (539) 34.6 (232)
% with nulliparity 17.2 (189) 16.4 (391) 16.7 (560) 15.5 (473) 14.4 (232) 13.0 (88) 0.003 0.10
Parity 1.90 (1.31) 1.96 (1.33) 1.97 (1.41) 2.12 (1.51) 2.21 (1.54) 2.31 (1.63) ,0.001 0.26
Pa
sedate 17.1 (190) 17.7 (425) 18.7 (633) 19.5 (598) 21.2 (344) 25.0 (173) ,0.001 0.64
Moderate 53.2 (591) 56.5 (1,357) 55.3 (1,878) 56.0 (1,718) 57.5 (935) 55.4 (383)
active 29.6 (329) 25.8 (619) 26.0 (882) 24.5 (751) 21.3 (346) 19.5 (135)
subjects with MI 0.8 (9) 0.9 (21) 1.3 (43) 1.9 (58) 1.8 (29) 2.2 (15) ,0.001 0.57
subjects with aP 1.6 (18) 2.0 (49) 3.2 (110) 4.0 (123) 4.6 (75) 5.6 (39) ,0.001 0.54
subjects with stroke 0.5 (6) 0.8 (19) 1.2 (40) 1.5 (45) 1.4 (23) 1.9 (13) 0.001 0.69
subjects with diabetes 1.3 (14) 1.5 (36) 1.5 (52) 2.0 (62) 1.9 (32) 2.6 (18) 0.008 0.29
subjects with heart attack 
or aP in close family
50.0 (527) 48.3 (1,113) 46.6 (1,512) 48.6 (1,411) 48.0 (739) 49.0 (317) 0.82 ,0.001
subjects with university 
education
37.4 (420) 32.2 (782) 31.8 (1,092) 26.5 (819) 23.3 (383) 20.2 (140) ,0.001 ,0.001
Note: Values are presented as percentage (number) or mean (sD).
Abbreviations: aaM, age at menarche; aP, angina pectoris; BMI, body mass index; HDl, high-density lipoprotein; MI, myocardial infarction; Pa, physical activity.
Table 2 relationships between aaM and all-cause mortality




Person-years HR* 95% CI HR** 95% CI
,12 1,120 (9.0) 112 21,849 1.06 0.87–1.31 1.05 0.85–1.29
12 2,428 (19.6) 302 46,702 0.99 0.86–1.14 0.96 0.83–1.11 
13 3,429 (27.6) 515 65,075 1 1
14 3,092 (24.9) 656 57,060 1.05 0.93–1.18 1.02 0.91–1.15 
15 1,646 (13.3) 410 29,682 1.00 0.87–1.13 0.99 0.86–1.12 
.15 694 (5.6) 208 12,201 1.09 0.93–1.29 1.05 0.89–1.23
p-value for linear trend 0.57 0.73
Notes: *Hr, adjusted for attained age only. **Hr, adjusted for the attained age, BMI, Pa, level of education, smoking.
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associations between aaM and 
demographic and lifestyle variables
Our study included 12,409 women. Mean age at the start of 
follow-up was 46.5 years.
The range of AAM according to the self-administered 
questionnaire was 8–21 years. Most females were 13 or 
14 years (27.6% and 24.9%, respectively) at menarche.
There was a strong, statistically significant positive 
relationship between AAM and age at baseline (p,0.001). 
Women who were ,12 years old at menarche were 11 years 
younger than women who were .15 years old (Table 1). 
Table 1 displays the unadjusted relationships between AAM 
and some potential confounding variables. We also gave 
the p-value for linear relationships both before and after 
adjustments for age. It is noted that adjustment for age had 
a strong impact on some of the relationships (eg, that for 
hypertension).
After age adjustment, AAM was significantly inversely 
associated with BMI, educational level, serum total cho-
lesterol, serum triglycerides and hypertension. The rela-
tionship with serum total cholesterol was of borderline 
significance, however. Age-adjusted serum high-density 
lipoprotein (HDL) cholesterol was positively associated 
with AAM (Table 1). Alcohol consumption, smoking, parity 
and PA were not significantly associated with AAM after 
adjusting for age.
AAM and the prevalence of diagnosed CVDs (previous 
heart attack, angina pectoris or stroke) were not significantly 
associated after adjusting for age, but the probability of 
having a family member with CVD was lower in women 
with high AAM (Table 1).
associations between aaM and total 
mortality
During the follow-up (mean 18.7 years), 2,203 women died.
There was no significant association between AAM and 
all-cause mortality before or after adjusting for possible 
confounding factors (Table 2). There was an indication of a 
U-shaped relationship between AAM and all-cause mortality, 
but the presence of a nonlinear trend was not supported by 
including a second-order term in the model.
When stratified for smoking habits (current smoking, 
previous smoking, never daily smoking), no association was 
found between AAM and total mortality in any of the three 
strata. In women with attained age of ,70 years (includ-
ing 453 deaths), we found some indications of a direct, 
positive relationship between AAM and total mortality 
(p-value for linear trend over the AAM categories =0.05), 
whereas no relationship was found in women with attained 
age of 70 years and older (1,750 deaths, p-value for linear 
trend over the AAM categories =0.7).
Discussion
This prospective, population-based study found no overall 
association between AAM and all-cause mortality before or 
after adjusting for confounding factors.
Most previous studies found a significant inverse relation-
ship between AAM and all-cause mortality.5,11 The review 
by Charalampopoulos et al,5 which included nine studies 
that investigated the relationship between AAM and all-
cause mortality, cardiovascular mortality, stroke and death 
from IHD, found an inverse association between AAM and 
death from all-causes. Two of the included studies showed a 
U-shaped association. Another study observed a U-shaped 
(or an inverted J-shaped) association between AAM and 
all-cause mortality with a higher all-cause mortality among 
those with high AAM (18 or 19 years) and among those with 
low AAM (,14 years) compared to AAM of 14 years.28 
In addition, the results of the current study may give hints of a, 
albeit statistically not significant, nonlinear relationship.
Similar to some previous studies,8 we found that there 
were relationships between AAM and some known risk 
factors for, inter alia, CVDs (Table 1). There was a consistent 
finding of inverse age-adjusted relationships between AAM 
and BMI, serum total cholesterol and triglycerides, low HDL 
cholesterol, hypertension and a family history of CVDs. 
Despite these relationships, we do not find an association 
between AAM and all-cause mortality.
Some studies have found a link between early AAM 
and higher occurrence of risk-taking behavior such as early 
sexual intercourse and more unprotected sex, early alcohol 
drinking and smoking.22,23 Such behavior could be attributed 
to the experiences of early maturation, and the feeling of 
entering adulthood could be strengthened by exploring what 
one considers as adult behavior. After adjusting for age, we 
found no association between AAM and smoking or alcohol 
consumption, however.
Some have suggested that women with late AAM, alone 
or in combination with a high menopausal age, could have 
lower mortality because they are biologically younger 
than their actual age.28 If the latter hypothesis was true, 
we expected increasing AAM to be associated with lower 
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age at menarche and total mortality: the Tromsø study
We have no obvious explanation to why our result contrasts 
with results from other studies.
limitations
This study has some limitations. We have no information 
regarding weight, height or PA level before menarche 
occurred. Although there is a strong tracking between 
childhood and adolescent BMI and BMI in adulthood,29–31 
these are important predictors for both AAM and mortality 
and should be taken into consideration. Other factors that 
could affect AAM are both excessive training and anorexia 
nervosa, which delay menarche32 and increase mortality. 
Potentially, there could be information bias due to the self-
report of behavioral factors such as smoking and alcohol 
consumption.
It is difficult to completely control for this potential 
bias other than by carrying out a prospective follow-up 
from pre-menarcheal childhood to adulthood to secure that 
the information regarding AAM and, for example, BMI in 
adolescence is valid. We have found a high reproducibility 
of self-reported AAM with a 7-year time span in the current 
population. If anything, the reproducibility was higher in 
older than in relatively young women.27 However, a high 
reproducibility does not equal validity, and it is difficult to 
know whether the self-reported AAM is the correct AAM. 
Thus, recall bias could be present also in our study. However, 
several studies have investigated the validity of self-reported 
AAM and have found relatively high correlations between 
self-reported AAM and the correct AAM (r=0.52–0.83), and 
that the mean recalled AAM does not differ significantly from 
the correct AAM, and concluded that self-reported AAM is 
accurate enough to be used in epidemiological studies.33–37 
Furthermore, to explain the lack of an inverse relationship 
between AAM and total mortality in our study by recall bias, 
we have to assume that, for example, older women (with 
higher mortality) have systematically reported a higher AAM 
than the correct AAM. Although we cannot completely rule 
this out, we do not find it likely.
strengths
This study has several strengths. It includes a large study 
sample of 12,409 women. The response rate in the Tromsø 
Study (Tromsø 4) is high, and after excluding those who 
did not report AAM, 65% of all women aged 25 years and 
older in the entire Tromsø municipality were included in 
our analyses. Living conditions in Tromsø are similar to 
those of other high-income countries, and there is reason to 
believe that the included women are representative for the 
general female population in Norway and probably other 
high-income countries, and that our results have external 
validity. Another strength is that physical examinations were 
performed by trained health care professionals. In addition, 
the participants were provided with guidance when answering 
the questionnaire and the risk of misunderstanding ques-
tions or wrongfully reporting from the physical examination 
is minimal.
Conclusion
We find no significant association between menarcheal age 
and all-cause mortality in the population in Tromsø. This 
result is contradictory to most previous findings, including 
our own,7,28 but we are currently not able to pinpoint the rea-
sons for this difference in findings. Adjustments for known 
possible confounders cannot explain our findings.
Ethics approval and informed 
consent
The Tromsø Study was approved by the Data Inspectorate of 
Norway and the Regional Committee of Medical and Health 
Research Ethics, North Norway (Reference: 2009/2536/
REK nord). Informed written consent was obtained from all 
individual participants included in the analyses.
Data availability
No data available. The results presented are based on analyses 
of the much larger Tromsø Study database, and each project 
must be authorized and data cannot be shared.
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